These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 1379506)

  • 21. Antiallergic mechanisms of beta-adrenergic stimulants in rats.
    Inagaki N; Miura T; Nagai H; Koda A
    Life Sci; 1992; 51(21):PL201-5. PubMed ID: 1279338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BL-5255, a tetrazolylpyrimidinone with potent oral antiallergy activity in animals.
    Siminoff P; Reed FC; Schurig JE; Juby PF
    Monogr Allergy; 1979; 14():318-23. PubMed ID: 91959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of immediate hypersensitivity reactions in laboratory animals by a phenanthroline salt (ICI 74,917).
    Evans DP; Thomson DS
    Br J Pharmacol; 1975 Mar; 53(3):409-18. PubMed ID: 48393
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the new antiallergic drug 11-oxo-11H-pyrido[2,1-b] quinazoline-2-carboxylic acid on type I allergic reactions.
    Kohno SW; Murata T; Kinoshita T; Ohata K
    Arzneimittelforschung; 1986 Nov; 36(11):1619-27. PubMed ID: 2434110
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-allergic properties of ethyl-3-methoxyphenyl-4-thiazolyl-2-oxamate (F 1865).
    Tarayre JP; Lauressergues H; Fauran F
    Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):165-76. PubMed ID: 6187305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiallergic activity and mode of action of N-[4-[4-(diphenylmethyl)-1-piperazinyl]butyl]-3-(6-methyl-3- pyridyl)acrylamide in experimental animals.
    Ishii K; Yakuo I; Seto Y; Kita A; Nakamura H; Nishikawa Y
    Arzneimittelforschung; 1993 Feb; 43(2):148-54. PubMed ID: 7681286
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo immunopharmacologic properties of a new antiallergic agent RHC 3414.
    Khandwala A; Sonnino-Goldman P; Leibowitz M; Dally-Meade V; Donigi-Ruzza D
    Arch Int Pharmacodyn Ther; 1984 Jan; 267(1):103-22. PubMed ID: 6202252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacologic characterization of the antiallergic activity of SK&F 78729-A.
    Chakrin LW; Krell RD
    J Pharmacol Exp Ther; 1978 Dec; 207(3):756-66. PubMed ID: 83359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibitory effects of beta-adrenergic stimulants on increased vascular permeability caused by passive cutaneous anaphylaxis, allergic mediators, and mediator releasers in rats.
    Inagaki N; Miura T; Daikoku M; Nagai H; Koda A
    Pharmacology; 1989; 39(1):19-27. PubMed ID: 2479953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bepotastine besilate, a highly selective histamine H(1) receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models.
    Kida T; Fujii A; Sakai O; Iemura M; Atsumi I; Wada T; Sakaki H
    Exp Eye Res; 2010 Jul; 91(1):85-91. PubMed ID: 20412793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The pharmacologic profile of wy-41,195, a new orally effective antiallergic agent.
    Carlson RP; Dervinis A; DiLuigi JM; Capetola RJ; Rosenthale ME; Lewis AJ
    Arzneimittelforschung; 1982; 32(12):1546-53. PubMed ID: 6186261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective effect of DS-4574, a peptidoleukotriene receptor antagonist, against endotoxin-induced intestinal injury in rats.
    Tabuchi Y; Furuhama K
    Eur J Pharmacol; 1995 Feb; 273(3):281-4. PubMed ID: 7737335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of SN-408 (salmeterol hydroxynaphthoate) on passive cutaneous anaphylaxis and anaphylactic chemical mediator release in rats and guinea pigs.
    Yamamura H; Kohno S; Ohata K
    Arerugi; 1991 Jul; 40(7):669-79. PubMed ID: 1718245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antiallergic activity of a disaccharide isolated from Sanguisorba officinalis.
    Park KH; Koh D; Kim K; Park J; Lim Y
    Phytother Res; 2004 Aug; 18(8):658-62. PubMed ID: 15472918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of SA-103 on experimental allergic models in vivo and in vitro--comparison with disodium cromoglycate.
    Nabe T; Yamamura H; Kohno S; Ohata K
    Arerugi; 1992 Jun; 41(6):676-85. PubMed ID: 1280084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and antiallergy activity of [1,3,4]thiadiazolo[3,2-a]-1,2,3-triazolo[4,5-d]pyrimidin-9 (3H)-one derivatives. I.
    Suzuki N; Miwa T; Aibara S; Kanno H; Takamori H; Tsubokawa M; Ryokawa Y; Tsukada W; Isoda S
    Chem Pharm Bull (Tokyo); 1992 Feb; 40(2):357-63. PubMed ID: 1606631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacology of a new orally active antiallergic: pyrido[1,2-a]pyrimidine, ucb L140 (CHINOIN 1045) in rats.
    De Vos C; Dessy F; Hermecz I; Meszaros Z; Breining T
    Int Arch Allergy Appl Immunol; 1982; 67(4):362-8. PubMed ID: 6175586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A comparison of the anti-anaphylactic activities of salbutamol and disodium cromoglycate in the rat, the rat mast cell and in human lung tissue.
    Butchers PR; Fullarton JR; Skidmore IF; Thompson LE; Vardey CJ; Wheeldon A
    Br J Pharmacol; 1979 Sep; 67(1):23-32. PubMed ID: 115530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug-induced modifications of the immune response. 1. Substituted 1-phenylisoquinolines.
    St Georgiev V; Carlson RP; Van Inwegen RG; Khandwala A
    J Med Chem; 1979 Apr; 22(4):348-52. PubMed ID: 85712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiallergic effects of major metabolites of astemizole in rats and guinea pigs.
    Kamei C; Mio M; Izushi K; Kitazumi K; Tsujimoto S; Fujisawa K; Adachi Y; Tasaka K
    Arzneimittelforschung; 1991 Sep; 41(9):932-6. PubMed ID: 1724600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.